
BCPC Earnings
Balchem Corp
- Overview
- Forecast
- Valuation
- Earnings
Earning Analysis
Welcome to our in-depth analysis of Balchem Corp(BCPC) earnings, offering investors a detailed look into the company’s financial performance, revenue trends, earnings per share (EPS), and market reactions. This page provides a comprehensive overview of Balchem Corp earnings history, forecasts, and key financial metrics, empowering you with the data needed to make informed investment decisions. Whether you're tracking quarterly results, analyzing earnings surprises, or exploring future projections, our detailed breakdown covers it all.
Earnings Forecast
Revenue
EPS
Currency: USD
Actual
Estimate
Surprise Analysis
FY2025Q2 | 2025-07-31 | Pre-Market | 1.25 | 1.27 | +1.60 | 250.31M | 255.47M | +2.06 | +0.25 | +2.85 |
FY2025Q1 | 2025-04-24 | Pre-Market | 1.25 | 1.22 | -2.40 | 245.70M | 250.52M | +1.96 | -2.60 | -1.45 |
FY2024Q4 | 2025-02-21 | Pre-Market | 1.11 | 1.03 | -7.21 | 239.96M | 240.00M | +0.02 | +1.48 | +6.61 |
FY2024Q3 | 2024-10-25 | Pre-Market | 1.03 | 1.13 | +9.71 | 241.93M | 239.94M | -0.82 | +3.19 | +0.70 |
FY2024Q2 | 2024-07-26 | - | 0.95 | 0.98 | +3.16 | 239.69M | 234.08M | -2.34 | +3.42 | +0.68 |
FY2024Q1 | 2024-05-03 | - | 0.94 | 0.89 | -5.32 | 232.46M | 239.66M | +3.10 | +2.82 | +5.97 |
FY2023Q4 | 2024-02-16 | - | 0.87 | 0.82 | -5.75 | 234.66M | 228.70M | -2.54 | +1.92 | +7.17 |
FY2023Q3 | 2023-10-27 | - | 0.91 | 0.90 | -1.10 | 237.08M | 229.95M | -3.01 | -5.42 | -2.28 |
FY2023Q2 | 2023-07-28 | - | 0.80 | 0.93 | +16.25 | 244.87M | 231.25M | -5.56 | +1.80 | +4.21 |
- | 2023-04-28 | - | 0.78 | 0.70 | -10.26 | - | - | - | +4.05 | +2.34 |
BCPC Earnings Analysis
Our earnings analysis provides a granular look at the company’s performance across recent fiscal quarters, highlighting key metrics such as revenue, EPS, and operating margins. By examining actual results against analyst estimates, we uncover trends and surprises that drive stock price movements, offering valuable insights for both short-term traders and long-term investors.
In the most recent quarter, Balchem Corp reported performance for FY2025Q2, announced on 2025-07-31. The company achieved an EPS of 1.27, compared to analyst estimates of 1.25 by 1.60% . Revenue for the quarter reached 255.47M compared to expectations of 250.31M by 2.06% .
The stock price reacted with a 0.25% one-day change and a 2.85% five-day change following the earnings release. These movements reflect market reaction in Balchem Corp growth trajectory and strategic initiatives.
BCPC Earnings Forecast
Looking ahead, Balchem Corp(BCPC) remains a focal point for investors seeking growth opportunities. Analyst forecasts for 2025/Q3 project quarter revenue of 249.80M and an EPS of 1.26.
However, recent estimate revisions provide additional context. Over the past three months, revenue estimates for FY2025 have been No Change by 0%, while EPS estimates have been No Change by 0%. For the upcoming Q3 2025, revenue estimates have been adjusted Revise Downward by -3.05% . These revisions correlate with a -0.73% change in stock price over the same period, suggesting potential buying opportunities for investors who believe in Balchem Corp long-term fundamentals.
The relationship between earnings forecast revisions and stock price movements is critical for investors. Positive revisions in revenue or EPS often signal strengthening fundamentals, making temporary price dips attractive entry points. Conversely, downward revisions may reflect short-term challenges.
Estimate Revision
The chart shows the correlation between BCPC's stock price and earnings forecast revisions. Positive revisions in Revenue or EPS often strengthen the stock's fundamentals, making price dips potential buying opportunities.
Revenue Estimates for FY2025
No Change

0.00%
In Past 3 Month
EPS Estimates for FY2025
No Change

0.00%
In Past 3 Month
Revenue Estimates for Q3 2025
Revise Downward

-3.05%
In Past 3 Month
Stock Price
Go Down

-0.73%
In Past 3 Month
1Y
3Y
5Y
Annual FY 2025
Currency: USD
1Y
3Y
5Y
--
Revenue Estimate-Annual FY 2025:1.02B
--
EPS Estimate-Annual FY 2025:5.08
—
Stock Price162.17
BCPC Revenue and EPS Performance: A Historical Perspective
Balchem Corp revenue and earnings per share (EPS) performance over recent quarters provides a clear picture of its financial health. Below is a detailed breakdown of the company’s earnings history, showcasing actual results, analyst estimates, and surprise percentages for key fiscal quarters:
FY2025Q2 (2025-07-31,Pre-Market):
EPS: 1.27 (Actual) vs.1.25 (Estimate) (1.60%)
Revenue: 255.47M (Actual) vs. 250.31M (Estimate) (2.06%)
Price Reaction: 0.25%(1-Day), 2.85%(5-Day)
FY2025Q1 (2025-04-24,Pre-Market):
EPS: 1.22 (Actual) vs.1.25 (Estimate) (-2.40%)
Revenue: 250.52M (Actual) vs. 245.70M (Estimate) (1.96%)
Price Reaction: -2.60%(1-Day), -1.45%(5-Day)
FY2024Q4 (2025-02-21,Pre-Market):
EPS: 1.03 (Actual) vs.1.11 (Estimate) (-7.21%)
Revenue: 240.00M (Actual) vs. 239.96M (Estimate) (0.02%)
Price Reaction: 1.48%(1-Day), 6.61%(5-Day)
Earnings Reaction
The chart below shows how BCPC performed 10 days before and after its earnings report, based on data from the past quarters. Typically, BCPC sees a -0.34% change in stock price 10 days leading up to the earnings, and a +2.85% change 10 days following the report. On the earnings day itself, the stock moves by +1.09%. This data can give you a slight idea of what to expect for the next quarter's release.
For example, in JUN/2025, the stock changed -0.20% on the day following the earnings release and then changed by 6.36% over the next 10 days. These patterns provide investors with valuable insights into potential price movements and help inform trading strategies around earnings events.
Transcript Summary
Balchem Corp (BCPC) Q2 2025 Earnings Call Summary
Positive
2025-08-01
Balchem's earnings call highlights strong financial performance, including record Q1 revenue and significant net income growth. The Animal Nutrition & Health segment shows promising growth, and the new manufacturing facility suggests future expansion. The Q&A section reveals stable demand and strategic investments, with some uncertainties around tariffs and specific timelines. Overall, the positive financial metrics and strategic initiatives outweigh the uncertainties, indicating a positive stock price reaction, particularly given the company's market cap size.
Balchem Corp (BCPC) Q1 2025 Earnings Call Summary
Positive
2025-04-24
Balchem's earnings call reflects strong financial performance with record revenue, earnings, and EBITDA. The company has a positive outlook for long-term growth and has increased its dividend, which is generally well-received by investors. Despite some concerns about tariffs and global trade, management is confident in its ability to mitigate these impacts. The Q&A session did not reveal significant negative sentiment, and the market cap suggests a moderate reaction. Overall, the positive financial results and optimistic guidance outweigh potential risks, suggesting a positive stock price movement in the short term.
Balchem Corp (BCPC) Q4 2024 Earnings Call Summary
Positive
2025-02-22
The earnings call summary reveals strong financial performance, including increased revenues, net income, and dividend growth, which is positive for shareholder returns. The Q&A section indicates management's confidence in handling potential tariff impacts and bird flu exposure, though some uncertainty remains. The company's strategic focus on product development and market expansion, coupled with a robust financial health and reduced debt, supports a positive sentiment. Considering the market cap, the stock is likely to experience a moderate positive reaction (2% to 8%) over the next two weeks.
Balchem Corporation (BCPC) Q3 2024 Earnings Call Summary
Positive
2024-10-25
The earnings call reveals strong financial performance with significant revenue and margin growth, a positive outlook for new products like Optifolin+, and effective debt reduction. The Q&A section supports optimism, highlighting increased demand in dairy and a promising product pipeline. While there are minor concerns in the ANH segment, the overall sentiment is positive, driven by robust financial metrics and strategic focus areas. With a market cap of approximately $4.9 billion, the stock is likely to see a positive movement of 2% to 8% over the next two weeks.
Balchem Corporation (BCPC) Q2 2024 Earnings Call Summary
Neutral
2024-07-26
The earnings call reveals mixed signals. Financial performance shows modest growth, with improved margins and reduced debt, but challenges in the Animal Nutrition segment and lack of shareholder return initiatives balance this out. The Q&A session highlights potential in new products and market opportunities, but also notes competitive pressures and supply chain issues. The lack of share repurchase or dividend announcements further tempers optimism. Given the market cap, the overall sentiment is neutral, expecting minimal stock price movement.
People Also Watch

SKY
Champion Homes Inc
73.200
USD
-1.59%

MAC
Macerich Co
17.510
USD
-2.01%

INGM
Ingram Micro Holding Corp
19.500
USD
-2.30%

PVH
PVH Corp
75.740
USD
-2.25%

SWX
Southwest Gas Holdings Inc
79.690
USD
-0.30%

IESC
IES Holdings Inc
347.270
USD
-0.30%

CUZ
Cousins Properties Inc
27.830
USD
-1.38%

LEA
Lear Corp
102.150
USD
-1.05%

AL
Air Lease Corp
57.903
USD
-0.70%

CIVI
Civitas Resources Inc
32.840
USD
-1.02%
FAQ

What were the key highlights of BCPC’s latest earnings report for FY2025Q2?
BCPC reported its FY2025Q2 earnings on 2025-07-31, showcasing a revenue of 255.47M against an estimate of 250.31M, resulting in a 2.06% surprise. The EPS was 1.27, surpassing the expected 1.25 by 1.6% . The stock experienced a 0.25% price change on the earnings day and a 2.85% change over the next five days, reflecting market reactions to the results.

How did BCPC’s stock price react after the FY2025Q2 earnings release?

What are the revenue and EPS estimates for BCPC for 2025/Q3?

How does BCPC’s stock price correlate with earnings forecast revisions?

What should investors expect from BCPC’s next earnings report?
